Company intelligence / Profile preview

Sygen International

Berkeley, California, United States

Ownership: Private
Employees: ~1500
Development stage: Other

Overview

Sygen International was a global leader in the application of quantitative genetics and biotechnology to animal breeding. The company primarily operated through its subsidiary, PIC (Pig Improvement Company), providing genetically superior breeding stock and technical support to the global pork industry. It also expanded into aquaculture through SyAqua, focusing on shrimp genetics. Sygen utilized molecular biology and genomic markers to improve traits such as growth rate, meat quality, and disease resistance. In 2005, the company was acquired by Genus plc, creating a world-leading animal breeding group.

Therapeutic areas: ImmunologyOther
Modalities: GenomicsMarker-assisted selectionQuantitative genetics
Industry: Agriculture & AgTech

Beyond the preview

Go deeper on Sygen International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sygen International.

Explore the full profile